Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | S-1 | tm2025599-3_s1.htm | S-1 | 2879378 |
| 2 | EXHIBIT 1.1 | tm2025599d4_ex1-1.htm | EX-1.1 | 181470 |
| 3 | EXHIBIT 3.1 | tm2025599d4_ex3-1.htm | EX-3.1 | 140268 |
| 4 | EXHIBIT 3.2 | tm2025599d4_ex3-2.htm | EX-3.2 | 108945 |
| 5 | EXHIBIT 3.3 | tm2025599d4_ex3-3.htm | EX-3.3 | 39127 |
| 6 | EXHIBIT 3.4 | tm2025599d4_ex3-4.htm | EX-3.4 | 191088 |
| 7 | EXHIBIT 4.1 | tm2025599d2_ex4-1.htm | EX-4.1 | 1614989 |
| 8 | EXHIBIT 4.3 | tm2025599d2_ex4-3.htm | EX-4.3 | 36063 |
| 9 | EXHIBIT 10.1 | tm2025599d4_ex10-1.htm | EX-10.1 | 97055 |
| 10 | EXHIBIT 10.2 | tm2025599d4_ex10-2.htm | EX-10.2 | 89183 |
| 11 | EXHIBIT 10.3 | tm2025599d4_ex10-3.htm | EX-10.3 | 63348 |
| 12 | EXHIBIT 10.4 | tm2025599d4_ex10-4.htm | EX-10.4 | 96565 |
| 13 | EXHIBIT 10.5 | tm2025599d4_ex10-5.htm | EX-10.5 | 64901 |
| 14 | EXHIBIT 10.9 | tm2025599d4_ex10-9.htm | EX-10.9 | 47365 |
| 15 | EXHIBIT 10.10 | tm2025599d4_ex10-10.htm | EX-10.10 | 19086 |
| 16 | EXHIBIT 10.11 | tm2025599d4_ex10-11.htm | EX-10.11 | 21967 |
| 17 | EXHIBIT 10.12 | tm2025599d4_ex10-12.htm | EX-10.12 | 46792 |
| 18 | EXHIBIT 10.13 | tm2025599d4_ex10-13.htm | EX-10.13 | 25808 |
| 19 | EXHIBIT 10.14 | tm2025599d4_ex10-14.htm | EX-10.14 | 132864 |
| 20 | EXHIBIT 10.15 | tm2025599d4_ex10-15.htm | EX-10.15 | 241355 |
| 21 | EXHIBIT 10.16 | tm2025599d4_ex10-16.htm | EX-10.16 | 147452 |
| 22 | EXHIBIT 10.17 | tm2025599d4_ex10-17.htm | EX-10.17 | 250121 |
| 23 | EXHIBIT 10.18 | tm2025599d4_ex10-18.htm | EX-10.18 | 136435 |
| 24 | EXHIBIT 10.19 | tm2025599d4_ex10-19.htm | EX-10.19 | 137488 |
| 25 | EXHIBIT 10.20 | tm2025599d4_ex10-20.htm | EX-10.20 | 687152 |
| 26 | EXHIBIT 23.1 | tm2025599d4_ex23-1.htm | EX-23.1 | 2065 |
| 27 | GRAPHIC | lg_immunome-4clr.jpg | GRAPHIC | 77317 |
| 28 | GRAPHIC | tm2025599d1-bc_signal4clr.jpg | GRAPHIC | 204014 |
| 29 | GRAPHIC | tm2025599d1-ph_donors4clr.jpg | GRAPHIC | 34798 |
| 30 | GRAPHIC | tm2025599d1-ph_engine4c.jpg | GRAPHIC | 35066 |
| 31 | GRAPHIC | tm2025599d1-ph_response4clr.jpg | GRAPHIC | 908468 |
| 32 | GRAPHIC | tm2025599d1-ph_target4clr.jpg | GRAPHIC | 933390 |
| 33 | GRAPHIC | tm2025599d1-ph_tumorbw.jpg | GRAPHIC | 468010 |
| 34 | GRAPHIC | tm2025599d1-ph_viral4clr.jpg | GRAPHIC | 817855 |
| 35 | GRAPHIC | tm2025599d3-bc_screenbw.jpg | GRAPHIC | 922093 |
| 36 | GRAPHIC | tm2025599d3-lc_figure134c.jpg | GRAPHIC | 1491781 |
| 37 | GRAPHIC | tm2025599d3-lc_figure54clr.jpg | GRAPHIC | 1642388 |
| 38 | GRAPHIC | tm2025599d3-ph_figure24clr.jpg | GRAPHIC | 2959317 |
| 39 | GRAPHIC | tm2025599d3-ph_figure34clr.jpg | GRAPHIC | 1310129 |
| 40 | GRAPHIC | tm2025599d3-ph_figure74clr.jpg | GRAPHIC | 1455601 |
| 41 | GRAPHIC | tm2025599d4_ex10-9img001.jpg | GRAPHIC | 4796 |
| Complete submission text file | 0001104659-20-103458.txt | 25227576 |
EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-248687 | Film No.: 201166712
SIC: 2834 Pharmaceutical Preparations